A [meso-tetrakis(4-sulfonatophenyl)porphyrinato] zinc(II) complex as an oral therapeutic for the treatment of type 2 diabetic KKAy mice

ChemMedChem

Volumn 2, Issue 2, 2007, Pages 218-225

  Saha, Tapan K ^a,b   Yoshikawa, Yutaka ^b   Sakurai, Hiromu ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Insulin; KKAy mice; Metabolic syndromes; Metalloporphyrin complexes; Zinc

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; LIGAND; METALLOPORPHYRIN; PORPHYRIN; TETRAPHENYLPORPHINE SULFONATE; UNCLASSIFIED DRUG; ZINC; ZINC SULFATE;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DRUG ADMINISTRATION ROUTE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; STRUCTURE ACTIVITY RELATION; TIME;

ADMINISTRATION, ORAL; ANIMALS; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION ROUTES; HYPOGLYCEMIC AGENTS; INSULIN; LIGANDS; METALLOPORPHYRINS; MICE; PORPHYRINS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; ZINC; ZINC SULFATE;

EID: 46649084259     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200600228     Document Type: Article

References (43)

1. S. Robin, V. Kumar, S. Cotran, Basic Pathology, Lippincot Pub., New York, 2003, p. 621.
2. I. Quraishi, S. Collins, J. P. Pestaner, T. Harris, O. Bagasra, Med. Hypotheses 2005, 65, 887-892.
3. L. C. Groop, Diabetes Care 1992, 15, 737-754.
4. D. K. Wysowski, G. Armstrong, L. Governale, Diabetes Care 2003, 26, 1852-1855.
5. S. E. Inzucchi, JAMA J. Am. Med. Assoc. 2002, 287, 360-372.
6. A. J. Karter, H. H. Moffet, J. Liu, M. M. Parker, A. T. Ahmed, A. Ferrara, J. V. Selby, Am. J. Manag. Care 2005, 11, 262-270.
7. L. Coulston, P. Dandona, Diabetes 1980, 29, 665-667.
8. J. M. May, C. S. Contoreggi, J. Biol. Chem. 1982, 257, 4362-4368.
9. O. Ezaki, J. Biol. Chem. 1989, 264, 16 118-16122.
10. A. Shisheva, D. Gffel, Y. Shechter, Diabetes 1992, 41, 982-988.
11. M. D. Chen, S. J. Liou, P. Y. Lin, V. C. Yang, P. S. Alexander, W. H. Lin, Biol. Trace Elem. Res. 1998, 61, 665-667.
12. Y. Yoshikawa, E. Ueda, K. Kawabe, H. Miyake, H. Sakurai, Y. Kojima, Chem. Lett. 2000, 874-875.
13. S. F. Simon, C. G. Taylor, Exp. Biol. Med. 2001, 226, 43-51.
14. Y. Yoshikawa, E. Ueda, K. Kawabe, H. Miyake, T. Takino, H. Sakurai, Y. Kojima, J. Biol. Inorg. Chem. 2001, 7, 68-73.
15. H. Sakurai, Y. Kojima, Y. Yoshikawa, K. Kawabe, H. Yasui, Coord. Chem. Rev. 2002, 226, 187-198.
16. J. Fugono, K. Fujimoto, H. Yasui, K. Kawabe, Y. Yoshikawa, Y. Kojima, H. Sakurai, Drug Metab. Pharmacokinet. 2002, 17, 340-347.
17. Y. Adachi, J. Yoshida, Y. Kodera, A. Kato, Y. Yoshikawa, Y. Kojima, H. Sakurai, J. Biol. Inorg. Chem. 2004, 9, 885-893.
18. M. J. Salgueiro, N. Krebs, M. B. Zubillaga, R. Weill, E. Postaire, A. E. Lysionek, R. A. Caro, T. DePaoli, A. Hager, J. Boccio, Biol. Trace Elem. Res. 2001, 81, 215-228.
19. K. C. M. De Sena, R. F. Arrais, M. D. G. Almeida, D. M. De Araujo, M. M. D. Santos, V. T. De Lima, L. De Fatima C. Pedrosa, Biol. Trace Elem. Res. 2005, 105, 1-9.
20. P. Faure, Clin. Chem. Lab. Med. 2003, 41, 995-998.
21. A. Bideci, M. O. Camurdan, P. Cinaz, H. Dursun, F. Demirel, J. Pediatr. Endocrinol. Metab. 2005, 18, 1007-1011.
22. E. R. Miranda, C. S. Dey, Biol. Trace Elem. Res. 2004, 101, 19-36.
23. th ed. Academic Press, New York, 1977, p. 196.
24. P. D. Zalewski, S. H. Millard, I. J. Forbes, O. Kapaniris, A. Slavotinek, W. H. Betts, A. D. Ward, S. F. Lincoln, I. Mahadevan, J. Histochem. Cytochem. 1994, 42, 877- 884.
25. Y. Yoshikawa, M. Kondo, H. Sakurai, Y. Kojima, J. Inorg. Biochem. 2005, 99, 1497-1503.
26. T. K. Saha, H. Sakurai, J. Pharm. Pharmacol., submitted.
27. T. K. Saha, Y. Yoshikawa, Y. Adachi, H. Sakurai, Biomed. Res. Trace Elem. 2005, 16, 328-331.
28. T. K. Saha, Y. Adachi, Y. Yoshikawa, H. Yasui, H. Sakurai, Chem. Lett. 2005, 34, 1350-1351.
29. T. K. Saha, Y. Yoshikawa, H. Yasui, H. Sakurai, Bull. Chem. Soc. Jpn. 2006, 79, 1191-1200.
30. A. D. Adler, F. R. Longo, F. Kampas, J. Kim, J. Inorg. Nucl. Chem. 1970, 32, 2443-2445.
31. K. M. Kadish, G. B. Maiya, C. Araullo, R. Guilard, Inorg. Chem. 1989, 28, 2725-2731.
32. M. Nakai, H. Watanabe, C. Fujiwara, H. Kakegawa, T. Satoh, J. Takeda, R. Matushita, H. Sakurai, Biol. Pharm. Bull. 1995, 18, 719-725.
33. Y. Adachi, H. Sakurai, Chem. Pharm. Bull. 2004, 52, 428-433.
34. Y. Adachi, Y. Yoshikawa, J. Yoshida, Y. Kodera, A. Katoh, Y. Kojima, H. Sakurai, Biomed. Res. Trace Elem. 2006, 17, 17-24.
35. Y. Yoshikawa, E. Ueda, H. Sakurai, Y. Kojima, Chem. Pharm. Bull. 2003, 51, 230-231.
36. R. J. Koenig, C. M. Peterson, C. Kilo, A. Cerami, J. R. Williamson, Diabetes 1976, 25, 230-232.
37. D. E. Goldstein, R. R. Little, R. A. Lorenz, J. I. Malone, D. Nathan, C. M. Peterson, D. B. Sacks, Diabetes Care 2004, 27, 1761-1773.
38. H. Nishioka, T. Yoshida, K. Yoshioka, M. Kondo, Endocrinol. Jpn. 1987, 34, 489-495.
39. J. E. Bleasidale, M. L. Swanson, Biochim. Biophys. Acta 1993, 1181, 240-248.
40. Y. Yoshikawa, E. Ueda, Y. Kojima, H. Sakurai, Life Sci. 2004, 75, 741-751.
41. H. Iwatsuka, A. Shino, Z. Suzuoki, Endocrinol. Jpn. 1970, 17, 23-35.
42. S. Taketomi, E. Ishikawa, H. Iwatsuka, Horm. Metab. Res. 1975, 7, 242-246.
43. A. Y. Chang, B. M. Wyse, E. J. Copeland, T. Peterson, S. R. Ledbetter, in Diabetes (Eds.: M. Serrano-Rios, P. J. Lefebvre), Elsevier, Amsterdam, 1986, pp. 466-470.